Roivant Sciences Ltd. (ROIV)
32.50
+4.29
(+15.21%)
USD |
NASDAQ |
May 20, 13:45
Roivant Sciences Market Cap : 23.26B for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arbutus Biopharma Corp. | 864.23M |
| Moderna, Inc. | 19.27B |
| Centessa Pharmaceuticals Plc | 6.149B |
| Silence Therapeutics Plc | 205.82M |
| Adaptimmune Therapeutics Plc | 5.010M |
Market Cap Related Metrics
| PS Ratio | 1688.12 |
| PEG Ratio | -0.0394 |
| Price to Book Value | 5.448 |
| Price | 32.50 |
| Earnings Yield | -3.60% |
| PEGY Ratio | -0.0394 |